Dow Up 1.30% Nasdaq Up 0.37%

Immunomedics Inc. (IMMU)

-NasdaqGM
4.00 0.03(0.76%) Oct 30, 4:00PM EDT
|After Hours : 3.97 Down 0.03 (0.75%) Oct 30, 5:10PM EDT
Prev Close:3.97
Open:3.98
Bid:3.29 x 5000
Ask:4.03 x 3000
1y Target Est:6.33
Beta:0.25
Next Earnings Date:N/A
Day's Range:3.89 - 4.13
52wk Range:3.04 - 6.17
Volume:1,387,673
Avg Vol (3m):645,453
Market Cap:372.46M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUUp 0.76%372.46M
BIIB75.81B
GSK108.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.88
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.46
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback